UniProtKB/Swiss-Prot P30307: Variant p.Arg70Cys

M-phase inducer phosphatase 3
Gene: CDC25C
Feedback?

Variant information Variant position:

70 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Cysteine (C) at position 70 (R70C, p.Arg70Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs3734166 [ dbSNP | Ensembl ]

Sequence information Variant position:

70 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

473 The length of the canonical sequence.
Location on the sequence:

VGKFLGDSANLSILSGGTPK R CLDLSNLSSGEITATQLTTS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VGK-FLGDSANLSILSGGTPKRCLDLSNLSSGEITATQLTTS

Mouse                         KDK--LHDSANLSILSGGTPKCCLDLSNLSSGEMSASPLTT

Pig                           LKKKLFGDSANLSILSGGTPKRCLDLSNLSSGEMSATQFTT

Bovine                        VEKKLFGDSANLSILSGGTPKRCLDLSNLSSGEMSATQLTA

Xenopus laevis                VTDLAVG-FSNLSTFSGETPKRCLDLSNL--GDETAPLPTE

Caenorhabditis elegans        ---------------------MCVDVP--------------

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 473	M-phase inducer phosphatase 3
Modified residue	57 – 57	Phosphoserine
Modified residue	61 – 61	Phosphoserine
Modified residue	64 – 64	Phosphoserine
Modified residue	67 – 67	Phosphothreonine
Alternative sequence	66 – 123	GTPKRCLDLSNLSSGEITATQLTTSADLDETGHLDSSGLQEVHLAGMNHDQHLMKCSP -> SPGFFRTSGSAFSWD. In isoform 4 and isoform 5.

Literature citations
Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.
Sadhu K.; Reed B.I.; Richardson H.; Russell P.;
Proc. Natl. Acad. Sci. U.S.A. 87:5139-5143(1990)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); DEVELOPMENTAL STAGE; VARIANT CYS-70; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1); VARIANT CYS-70; Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C.
Wegener S.; Hampe W.; Herrmann D.; Schaller H.C.;
Eur. J. Cell Biol. 79:810-815(2000)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 32-210 (ISOFORMS 2; 4 AND 5); VARIANT CYS-70;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.